Medications like Mounjaro were originally developed to help people with Type 2 diabetes control their blood sugar. However, as demand surged for weight loss treatments, drugmakers like Eli Lilly and Company expanded Mounjaro’s use. Now, this once-promising drug is the subject of growing concern—and mounting lawsuits.
Many users have reported serious gastrointestinal problems, including gastroparesis, or stomach paralysis, after taking Mounjaro. Mounjaro stomach paralysis lawsuits have claimed that the manufacturer failed to properly warn the public about these risks. Recently, more information has come to light that links Mounjaro with other serious health conditions.
If you’ve experienced severe side effects after using Mounjaro, you may be entitled to compensation.
At Dolman Law Group, we are laying the groundwork to bring product liability lawsuits against negligent pharmaceutical companies for our injured clients. We encourage you to schedule a free consultation with our experienced team to discuss your Mounjaro lawsuit by calling us at (727) 451-6900 or completing our online contact form today.
The Most Recent Mounjaro Lawsuit Updates
As the Mounjaro case starts to move forward, we will be gathering updates here.
April 1, 2025—Steady Increase in Lawsuit Filings
The number of Mounjaro lawsuits has continued to rise sharply in 2025. According to federal court data, more than 1,500 lawsuits involving Mounjaro and similar GLP-1 receptor agonists have now been filed. In February 2025 alone, at least 78 new cases entered the federal system, following 110 cases in January. By early April, filings had increased by an estimated 17% over the previous quarter.
Most claims involve serious complications like:
- Stomach paralysis (gastroparesis)
- Persistent vomiting and nausea
- Gallbladder disease
- Acid reflux and esophageal damage
The lawsuits accuse Eli Lilly and other drugmakers of aggressively marketing GLP-1 drugs for weight loss without fully disclosing their potential to cause life-altering gastrointestinal injuries.
MDL Consolidation Status
The GLP-1 MDL No. 3094 in Philadelphia is now well-established as the forum for pretrial proceedings in these cases
All lawsuits in the MDL share common questions of fact about the drugs’ propensity to cause gastroparesis, delayed gastric emptying, and related gastrointestinal injuries and whether Lilly and Novo Nordisk knew of these risks and adequately warned patients and doctors
The MDL structure allows coordinated discovery and rulings on overarching issues, avoiding duplicate efforts in courts nationwide. As mentioned, the JPML refined the MDL’s scope in December 2024—at that time, the panel agreed to add Saxenda cases (since Saxenda, like Mounjaro and Ozempic, is a GLP-1 agonist alleged to cause similar stomach paralysis injuries)
However, the JPML rejected requests to include claims for injuries like deep vein thrombosis (DVT) and pulmonary embolism in the MDL, citing concerns that adding unrelated complications would make the litigation too complex and dissimilar
Upcoming Timeline
- April 21, 2025: Status conference scheduled
- May 19, 2025: Next MDL hearing
- Late 2026 or early 2027: Expected timing for first bellwether trials
These trials will help shape potential settlement discussions for future claims and provide insight into how juries may respond to the allegations.
First Hearing Concerning the Mounjaro MDL Lawsuit Held on March 14, 2024 in Philadelphia
The Philadelphia federal court ihosted the first hearing of the lawsuit against the diabetes medication Mounaro due to its various serious side effects, most notably stomach paralysis.
The initial hearing was essential in determining what will happen next in the lawsuit. It was a chance for the injured defendants, their lawyers, and other important parties to share their initial arguments and evidence, as well as to hear from the plaintiffs and get insight into their strategy. This early stage was crucial for shaping the direction of the lawsuit and gave us some clues about how things will likely play out.
This case has caught the attention of America because so many people are using drugs like Mounaro, Ozempic, and Wegovy to achieve rapid weight loss. Over 70% of American adults are overweight or obese, so there’s this massive market for these so-called “miracle drugs.” Unfortunately, there is a real lack of information, which has caused many people to develop serious unwanted and unwarned side effects.
Stay tuned to Dolman Law Group for further updates on the Mounjaro case as we continue to monitor the proceedings.
The Mounjaro Stomach Paralysis Attorneys of Dolman Law Group Can Offer Exceptional Legal Guidance
One of the most critical decisions you will make about your product liability claim is which personal injury attorney you hire. The product liability lawyers of Dolman Law Group have cultivated a nationwide client base founded on our considerable resources, high standards for service, and ability to maximize compensation for our clients. We are the relentless team you need to establish liability and negotiate a fair settlement for your Mounjaro stomach paralysis lawsuit.
Over the past decade, the mass tort attorneys of Dolman Law Group have been at the forefront of the effort to assist consumers with seeking justice from negligent major pharmaceutical companies like Eli Lilly by pursuing product liability lawsuits to help clients recover compensation for their damages. This includes prominent issues like the Tepezza hearing loss claims and the Zantac cancer lawsuits. Our team is also currently representing clients in the Ozempic stomach paralysis lawsuits. We have secured millions of dollars in compensation for clients to offset harm to their careers, health, and finances.
At Dolman Law Group, we firmly believe that every client’s experience matters, and we will provide your product liability lawsuit with the attention it deserves. Our award-winning personal injury attorneys are recognized for their record of success and high rates of client satisfaction, which is a point of pride for our team. Mounjaro users who have suffered the extensive financial and emotional costs of stomach paralysis can benefit from our years of experience and detail-oriented approach.
Mounjaro Users Say the Medication Has Alarming Side Effects Including Stomach Paralysis
Recent product liability lawsuits claim that Eli Lilly and other drug manufacturers like Novo Nordisk have negligently excluded the full range of possible complications from their product’s warning labels, leaving unwitting patients susceptible to serious injuries like stomach paralysis. Specifically, Mounjaro users have complained of gastroparesis, in addition to the minor side effects listed on the product, such as nausea.
Medications like Mounjaro work to help Type II diabetics deal with excess sugar in their blood. In addition to bolstering insulin production, Mounjaro slows the progression of food through the stomach to the small intestine. This becomes problematic when the slower speed impairs the digestive process so the food can’t move to the next stage. Gastroparesis, also known as stomach paralysis, refers to a condition where the food is stuck in the stomach for a prolonged period.
Symptoms of gastroparesis include:
- Vomiting and nausea
- Loss of appetite or feeling full for a long time
- Heartburn
- Constipation
- Dyspepsia, also known as indigestion
- Pain or discomfort
- Bloating
Over time, gastroparesis can lead to adverse health outcomes. For example, if you constantly feel full, you may not consume enough food to obtain the water and nutrients your body needs, which may turn into dehydration and malnutrition. Another concern is damage to the teeth and esophagus caused by corrosive stomach acid, which can happen if the patient is experiencing vomiting or acid reflux.
Ironically, gastroparesis can also create issues with blood sugar levels, which Mounjaro should address. In extreme cases of gastroparesis, surgical intervention may be necessary if the food has hardened to the point where it cannot be digested normally.
Can Mounjaro Cause Gastroparesis?
Many users are now asking: Does Mounjaro cause stomach paralysis? While Mounjaro’s warning label does mention “delayed gastric emptying,” it fails to explicitly list gastroparesis or severe GI complications as a possible side effect.
Several lawsuits argue that Eli Lilly’s failure to clearly communicate these risks left patients vulnerable to unexpected harm.
How Mounjaro’s Active Ingredients Cause Stomach Paralysis
Like Ozempic, Mounjaro is a glucagon-like peptide-1 (GLP-1) receptor agonist medication. When a drug has an agonist component, that element replaces the hormone that the patient is missing. In the case of Mounjaro, the Semaglutide portion of the medication fulfills the role of a Type II diabetic’s GLP-1 hormone, which would typically increase insulin production and limit glucagon. GLP-1 drugs can also restrain the gastric emptying stage of digestion.
Although Mounjaro manufacturers face criticisms similar to those of the makers of fellow Type II diabetes drug Ozempic, Mounjaro is not exclusively a Semaglutide-based medication. Mounjaro relies on Tirzepatide, which is a GLP-1 receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) agonist. When acting as a GIP, Mounjaro can increase insulin output further to control high blood sugar levels.
Mounjaro’s multifaceted approach means that Type II diabetics may consume less food, contributing less sugar to the body, which is better equipped to process the sugar it does receive. The issue with Mounjaro and similar medications is that in delaying the emptying of the stomach’s contents, the nerves that signal the stomach muscles to contract can be compromised, leading to stomach paralysis. As a result, the food being digested becomes trapped because there is insufficient momentum to send the materials to the small intestine.
Plaintiffs Claim Mounjaro Manufacturer Did Not Accurately Describe Risks of Weight Loss Drug
Accurate warning labels on prescription medications are more important than ever as weight-loss medications like Mounjaro are increasingly accessible. Pharmaceutical manufacturer Eli Lilly has even created a telehealth website where patients can obtain prescriptions for Mounjaro remotely. As it stands, Mounjaro’s warning label does reference “delayed gastric emptying” as a potential side effect of using the Tirzepatide, though it does not specify gastroparesis as a possible complication.
One of the first plaintiffs in the Semaglutide stomach paralysis lawsuits, Jaclyn Bjorklund of Louisiana, has filed a claim alleging that Eli Lilly knew or should have been aware of the drug’s ability to cause stomach paralysis and therefore had a legal duty to warn the public. For the company to be found liable, she must demonstrate that her gastroparesis and ensuing damages are the result of the drug manufacturer’s failure to correctly describe the risks of using their medication.
The pharmaceutical company argues that gastroparesis is often associated with Type II diabetes and should not be attributed to Mounjaro. While it is true that diabetes is a leading cause of gastroparesis, plaintiffs argue that it does not explain cases where Mounjaro users experienced gastroparesis only after taking the medication, particularly for those who were not Type II diabetics. Both sides will hopefully have the opportunity to present their positions in court soon, as plaintiffs have requested that the Ozempic and Mounjaro stomach paralysis lawsuits be consolidated into a multidistrict litigation.
Mounjaro and Gallbladder Disease Lawsuits
Beyond gastroparesis, many Mounjaro users have reported gallbladder complications, including:
- Gallstones
- Gallbladder inflammation (cholecystitis)
- Bile duct obstruction
The lawsuits allege that Mounjaro increases the risk of gallbladder issues by impairing normal digestive function. Although gallbladder disease is not listed as a prominent risk on Mounjaro’s label, plaintiffs argue that the manufacturer knew—or should have known—about this danger.
These issues have given rise to a distinct group of Mounjaro gallbladder lawsuits, now being filed alongside those related to stomach paralysis.
What Is the Difference Between the Mounjaro Lawsuit and a Class Action?
This litigation is a multidistrict litigation (MDL), not a class action. Here’s what that means:
- MDL lawsuits are filed individually, allowing for compensation based on each person’s unique injuries.
- Class actions treat all plaintiffs as a single group, often with smaller payouts.
- In MDL 3094, your case will still be evaluated independently, even though pretrial proceedings are handled together.
What to Do If You’ve Experienced Mounjaro Side Effects
If you’ve developed symptoms like severe acid reflux, nausea, stomach pain, or gastroparesis after taking Mounjaro, don’t ignore them. You should:
- Seek medical care immediately.
- Document your diagnosis and treatment history.
- Save prescription records and pharmacy receipts.
- Contact a product liability attorney to evaluate your case.
Early intervention can make a major difference in both your health and your legal rights.
Product Liability Lawsuits Offer Plaintiffs the Opportunity for Compensation for Their Damages
Tapping into the multi-billion dollar weight loss market is tempting for many drug manufacturers. Still, it should not come at the price of patients’ physical and mental health or financial stability. Mounjaro users are now seeking compensation for their costs due to developing stomach paralysis in product liability lawsuits. Should they succeed in establishing Eli Lilly’s liability, plaintiffs may be able to recover compensation for damages such as:
- Medical bills, including tests, dental work, and surgery
- Lost wages
- Emotional distress
- Pain and suffering
- Loss of quality of life
- Cost of the medication
Healing from gastroparesis can be time-consuming, and you may suffer additional complications like an infection at the surgical site. As a result, you may need to delay returning to work or resuming your previous household responsibilities, exacerbating existing financial and logistical stressors.
It is common for plaintiffs to endure intangible losses as they navigate severe medical conditions like gastroparesis, such as a reduced quality of life after being hospitalized with a feeding tube to treat malnutrition related to their stomach paralysis. Both economic and non-economic damages are eligible for compensation in a Mounjaro stomach paralysis lawsuit.
Frequently Asked Questions About the Mounjaro Stomach Paralysis Lawsuits
What does it cost to hire a Mounjaro stomach paralysis attorney?
You can access the legal services of a personal injury attorney at no out-of-pocket cost. After your product liability lawyer has settled your Mounjaro stomach paralysis lawsuit, they recover a contingency fee from your settlement. Typically, a contingency fee is about 33% of the final settlement, although courts can impose caps in certain situations. Their services are based on a percentage of the compensation they get you, so if they do not settle your Mounjaro stomach paralysis claim, you pay nothing.
Is Mounjaro Approved for Weight Loss?
As of April 2025, Mounjaro is FDA-approved for managing Type 2 diabetes, not weight loss. However, its off-label use for weight reduction has exploded in popularity. Eli Lilly also markets a similar tirzepatide-based medication called Zepbound, which received FDA approval for weight loss in late 2023.
Is Mounjaro the same thing as Ozempic?
Ozempic and Mounjaro are both medications prescribed to treat Type II diabetes. Patients receive regular injections of the GLP-1 agonists that are intended to help balance blood sugar levels. The primary distinction between Ozempic and Mounjaro is that Ozempic is a brand name for a class of medications called Semaglutide, while Mounjaro is a Tirzepatide medication that also includes a glucose-dependent insulinotropic polypeptide component. Plaintiffs are also pursuing Ozempic stomach paralysis lawsuits based on similar allegations of negligence.
Why You Should Hire a Product Liability Lawyer to Represent Your Mounjaro Stomach Paralysis Claim
Injuries like gastroparesis can disrupt your daily life and your future financial stability. Choosing to file a product liability claim without the guidance of a qualified personal injury lawyer can jeopardize the compensation you need to offset these costs and create further stress. The parties evaluating the validity of your product liability claim are also more likely to consider your case seriously if an established personal injury lawyer with a background in defective drug lawsuits represents you.
Given the disputes over the precise cause of Mounjaro users’ gastroparesis, you should also decide to enlist the expertise of a product liability lawyer to not only accumulate reliable evidence of a causal relationship but also to assemble that evidence into a cohesive case. They have the staff and resources to accomplish this in a timely manner while overseeing the ongoing administrative side of filing a personal injury lawsuit, such as submitting requests for documents and scheduling depositions.
Furthermore, product liability lawyers have knowledge of the tactics defendants may employ to disenfranchise Mounjaro plaintiffs and how to protect the value of their client’s damages, resulting in better settlement outcomes. If you are suffering from gastroparesis related to Mounjaro, you should be able to make your health your priority, and a capable personal injury lawyer can allow you to do that by managing the details of your case.
Contact Dolman Law Group For Help With Your Mounjaro Stomach Paralysis Lawsuit
The defective drug lawyers of Dolman Law Group have been a respected name in personal injury law for the past decade, establishing ourselves as highly effective negotiators with a focus on client satisfaction. Our skilled team of Mounjaro stomach paralysis lawyers can offer you exceptional legal advice as you navigate the personal injury claims process to secure the compensation you deserve for your medical expenses, lost wages, and pain and suffering.
We encourage you to put your Mounjaro stomach paralysis lawsuit in the best position to recover maximum compensation by contacting the personal injury lawyers of Dolman Law Group at (727) 451-6900 or completing our online contact form to schedule a free consultation as soon as possible. Our team of product liability attorneys values your trust and will relentlessly seek a fair settlement for the damages you have sustained in your Mounjaro stomach paralysis lawsuit.